Published in Neuropsychopharmacology on March 01, 1998
Neurocircuitry of addiction. Neuropsychopharmacology (2010) 14.22
Dopamine reward circuitry: two projection systems from the ventral midbrain to the nucleus accumbens-olfactory tubercle complex. Brain Res Rev (2007) 6.36
Addiction and substance abuse in anesthesiology. Anesthesiology (2008) 5.57
Reconsidering anhedonia in depression: lessons from translational neuroscience. Neurosci Biobehav Rev (2010) 3.46
It is not "either/or": activation and desensitization of nicotinic acetylcholine receptors both contribute to behaviors related to nicotine addiction and mood. Prog Neurobiol (2007) 2.85
The neurobiology of anhedonia and other reward-related deficits. Trends Neurosci (2011) 2.36
Endogenous cardiotonic steroids: physiology, pharmacology, and novel therapeutic targets. Pharmacol Rev (2009) 2.17
Removing obstacles in neuroscience drug discovery: the future path for animal models. Neuropsychopharmacology (2008) 2.16
Cognitive dysfunction and anxious-impulsive personality traits are endophenotypes for drug dependence. Am J Psychiatry (2012) 2.05
Differential role of nicotinic acetylcholine receptor subunits in physical and affective nicotine withdrawal signs. J Pharmacol Exp Ther (2008) 2.04
Acute withdrawal, protracted abstinence and negative affect in alcoholism: are they linked? Addict Biol (2010) 1.93
Nicotine receptors and depression: revisiting and revising the cholinergic hypothesis. Trends Pharmacol Sci (2010) 1.71
The one-two punch of alcoholism: role of central amygdala dynorphins/kappa-opioid receptors. Biol Psychiatry (2013) 1.69
Behavioral functions of the mesolimbic dopaminergic system: an affective neuroethological perspective. Brain Res Rev (2007) 1.50
Bupropion enhances brain reward function and reverses the affective and somatic aspects of nicotine withdrawal in the rat. Psychopharmacology (Berl) (2003) 1.49
Distinctions between bipolar and unipolar depression. Clin Psychol Rev (2005) 1.42
Corticotropin-releasing factor-1 receptor activation mediates nicotine withdrawal-induced deficit in brain reward function and stress-induced relapse. Biol Psychiatry (2009) 1.38
A systematic review of longitudinal studies on the association between depression and smoking in adolescents. BMC Public Health (2009) 1.35
Nonmedical use of prescription stimulants and depressed mood among college students: frequency and routes of administration. J Subst Abuse Treat (2010) 1.33
Effects of stress on alcohol drinking: a review of animal studies. Psychopharmacology (Berl) (2011) 1.33
Opioid receptors: distinct roles in mood disorders. Trends Neurosci (2012) 1.31
Pathways between nonmedical opioid use/dependence and psychiatric disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Drug Alcohol Depend (2009) 1.30
Development of pharmacotherapies for drug addiction: a Rosetta stone approach. Nat Rev Drug Discov (2009) 1.30
Mood disorders and substance use disorder: a complex comorbidity. Sci Pract Perspect (2005) 1.29
Blockade of kappa opioid receptors attenuates the development of depressive-like behaviors induced by cocaine withdrawal in rats. Neuropharmacology (2011) 1.29
Nicotinic partial agonists varenicline and sazetidine-A have differential effects on affective behavior. J Pharmacol Exp Ther (2010) 1.24
Depressive-like effects of the kappa opioid receptor agonist salvinorin A are associated with decreased phasic dopamine release in the nucleus accumbens. Psychopharmacology (Berl) (2010) 1.24
Subtypes of nicotinic acetylcholine receptors in nicotine reward, dependence, and withdrawal: evidence from genetically modified mice. Behav Pharmacol (2008) 1.23
κ-opioid receptors are implicated in the increased potency of intra-accumbens nalmefene in ethanol-dependent rats. Neuropharmacology (2011) 1.23
Effects of the CRF receptor antagonist D-Phe CRF(12-41) and the alpha2-adrenergic receptor agonist clonidine on stress-induced reinstatement of nicotine-seeking behavior in rats. Neuropharmacology (2007) 1.17
Nicotine exposure during adolescence induces a depression-like state in adulthood. Neuropsychopharmacology (2008) 1.15
Cognitive processes in alcohol binges: a review and research agenda. Curr Drug Abuse Rev (2008) 1.15
Roles of neural stem cells and adult neurogenesis in adolescent alcohol use disorders. Alcohol (2010) 1.15
Targeting dynorphin/kappa opioid receptor systems to treat alcohol abuse and dependence. Alcohol (2012) 1.12
Contributions of serotonin in addiction vulnerability. Neuropharmacology (2011) 1.12
Repeated exposure to the κ-opioid receptor agonist salvinorin A modulates extracellular signal-regulated kinase and reward sensitivity. Biol Psychiatry (2011) 1.10
Corticotropin-releasing factor within the central nucleus of the amygdala and the nucleus accumbens shell mediates the negative affective state of nicotine withdrawal in rats. Neuropsychopharmacology (2009) 1.08
Evaluation of reward processes in an animal model of depression. Psychopharmacology (Berl) (2006) 1.07
Exposure to the selective kappa-opioid receptor agonist salvinorin A modulates the behavioral and molecular effects of cocaine in rats. Neuropsychopharmacology (2008) 1.07
The locus coeruleus: A key nucleus where stress and opioids intersect to mediate vulnerability to opiate abuse. Brain Res (2009) 1.06
Meta-analysis of depression and substance use and impairment among cocaine users. Drug Alcohol Depend (2008) 1.05
Decreased brain reward function during nicotine withdrawal in C57BL6 mice: evidence from intracranial self-stimulation (ICSS) studies. Pharmacol Biochem Behav (2008) 1.04
Deficits in a sustained attention task following nicotine withdrawal in rats. Psychopharmacology (Berl) (2004) 1.04
Substance abuse in patients with schizophrenia. Dialogues Clin Neurosci (2006) 1.02
Progesterone modulation of alpha5 nAChR subunits influences anxiety-related behavior during estrus cycle. Genes Brain Behav (2009) 1.00
Cigarette smoking and the onset and persistence of depression among adults in the United States: 1994-2005. Compr Psychiatry (2014) 1.00
Withdrawal from chronic exposure to amphetamine, but not nicotine, leads to an immediate and enduring deficit in motivated behavior without affecting social interaction in rats. Behav Pharmacol (2010) 0.99
Anhedonia associated with stimulant use and dependence in a population-based sample of American adults. Exp Clin Psychopharmacol (2010) 0.98
Schizophrenia and tobacco smoking comorbidity: nAChR agonists in the treatment of schizophrenia-associated cognitive deficits. Neuropharmacology (2011) 0.97
Mood-related drinking motives mediate the familial association between major depression and alcohol dependence. Alcohol Clin Exp Res (2009) 0.97
Measuring reinforcement learning and motivation constructs in experimental animals: relevance to the negative symptoms of schizophrenia. Neurosci Biobehav Rev (2013) 0.95
The Purpose in Chronic Addiction. AJOB Neurosci (2012) 0.95
Investigating the possible causal association of smoking with depression and anxiety using Mendelian randomisation meta-analysis: the CARTA consortium. BMJ Open (2014) 0.94
Association between coping with anger and feelings of depression among youths. Am J Public Health (2006) 0.94
Effects of prolonged ethanol vapor exposure on forced swim behavior, and neuropeptide Y and corticotropin-releasing factor levels in rat brains. Alcohol (2010) 0.94
Socioeconomic position and HIV risk-relevant behavior among lower-income heterosexuals in San Francisco. AIDS Behav (2011) 0.94
The kappa opioid receptor: from addiction to depression, and back. Front Psychiatry (2014) 0.94
Stimulation of α2-adrenergic receptors in the central nucleus of the amygdala attenuates stress-induced reinstatement of nicotine seeking in rats. Neuropharmacology (2010) 0.92
The role of various nicotinic receptor subunits and factors influencing nicotine conditioned place aversion. Neuropharmacology (2009) 0.92
The effect of intermittent alcohol vapor or pulsatile heroin on somatic and negative affective indices during spontaneous withdrawal in Wistar rats. Psychopharmacology (Berl) (2012) 0.92
Ventral striatal blood flow is altered by acute nicotine but not withdrawal from nicotine. Neuropsychopharmacology (2007) 0.92
Pharmacogenetics of smoking cessation: role of nicotine target and metabolism genes. Hum Genet (2012) 0.92
The bidirectional relationships between alcohol, cannabis, co-occurring alcohol and cannabis use disorders with major depressive disorder: results from a national sample. J Affect Disord (2012) 0.91
Reconceptualizing anhedonia: novel perspectives on balancing the pleasure networks in the human brain. Front Behav Neurosci (2015) 0.91
Fluoxetine, desipramine, and the dual antidepressant milnacipran reduce alcohol self-administration and/or relapse in dependent rats. Neuropsychopharmacology (2011) 0.91
Five-factor model personality traits in opioid dependence. BMC Psychiatry (2007) 0.91
Association between nicotine withdrawal and reward responsiveness in humans and rats. JAMA Psychiatry (2014) 0.91
Methoxetamine (MXE)--a phenomenological study of experiences induced by a "legal high" from the internet. J Psychoactive Drugs (2013) 0.90
The Association of Cigarette Smoking With Depression and Anxiety: A Systematic Review. Nicotine Tob Res (2016) 0.90
Nicotine and nicotinic receptor antagonists potentiate the antidepressant-like effects of imipramine and citalopram. Br J Pharmacol (2003) 0.90
Effects of NPY and the specific Y1 receptor agonist [D-His(26)]-NPY on the deficit in brain reward function and somatic signs associated with nicotine withdrawal in rats. Neuropeptides (2008) 0.90
The habenulo-interpeduncular pathway in nicotine aversion and withdrawal. Neuropharmacology (2014) 0.89
Failure to improve cigarette smoking abstinence with transdermal selegiline + cognitive behavior therapy. Addiction (2010) 0.89
A longitudinal investigation of the role of self-medication in the development of comorbid mood and drug use disorders: findings from the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC). J Clin Psychiatry (2012) 0.89
Intimate partner violence victimization and cigarette smoking: a meta-analytic review. Trauma Violence Abuse (2013) 0.88
Using Mendelian randomisation to infer causality in depression and anxiety research. Depress Anxiety (2013) 0.88
Inactivation of the 5-HT(7) receptor partially blocks phencyclidine-induced disruption of prepulse inhibition. Biol Psychiatry (2007) 0.88
Involvement of metabotropic glutamate receptor 5 in brain reward deficits associated with cocaine and nicotine withdrawal and somatic signs of nicotine withdrawal. Psychopharmacology (Berl) (2011) 0.88
Precipitated withdrawal from nicotine reduces reinforcing effects of a visual stimulus for rats. Nicotine Tob Res (2012) 0.87
Contribution of hypothalamic-pituitary-adrenal activity and environmental stress to vulnerability for smoking in adolescents. Neuropsychopharmacology (2009) 0.87
Animal models of nicotine exposure: relevance to second-hand smoking, electronic cigarette use, and compulsive smoking. Front Psychiatry (2013) 0.87
Acute psychomotor, subjective and physiological responses to smoking in depressed outpatient smokers and matched controls. Psychopharmacology (Berl) (2006) 0.87
Vulnerability to the rapid ("telescoped") development of alcohol dependence in individuals with anxiety disorder. J Stud Alcohol Drugs (2011) 0.87
Psychopathology and the Ability to Do Otherwise. Philos Phenomenol Res (2015) 0.87
Paroxetine combined with a 5-HT(1A) receptor antagonist reversed reward deficits observed during amphetamine withdrawal in rats. Psychopharmacology (Berl) (2004) 0.87
Does variance in drinking motives explain the genetic overlap between personality and alcohol use disorder symptoms? A twin study of young women. Alcohol Clin Exp Res (2011) 0.86
Effects of prazosin, clonidine, and propranolol on the elevations in brain reward thresholds and somatic signs associated with nicotine withdrawal in rats. Psychopharmacology (Berl) (2010) 0.86
Effect of tryptophan depletion on the attentional salience of smoking cues. Psychopharmacology (Berl) (2007) 0.86
Alexithymia and stress-induced brain activation in cocaine-dependent men and women. J Psychiatry Neurosci (2006) 0.86
The catecholaminergic-cholinergic balance hypothesis of bipolar disorder revisited. Eur J Pharmacol (2014) 0.86
Psychiatric comorbidity among adults with schizophrenia: a latent class analysis. Psychiatry Res (2013) 0.85
Self-efficacy mediates the effect of depression on smoking susceptibility in adolescents. Nicotine Tob Res (2011) 0.85
Immunocytochemical study of the forebrain serotonergic innervation in Sardinian alcohol-preferring rats. Psychopharmacology (Berl) (2003) 0.85
Plasticity associated with escalated operant ethanol self-administration during acute withdrawal in ethanol-dependent rats requires intact matrix metalloproteinase systems. Neurobiol Learn Mem (2011) 0.85
L-type calcium channels and calcium/calmodulin-dependent kinase II differentially mediate behaviors associated with nicotine withdrawal in mice. J Pharmacol Exp Ther (2009) 0.85
The effects of subanesthetic ketamine infusions on motivation to quit and cue-induced craving in cocaine-dependent research volunteers. Biol Psychiatry (2013) 0.84
DRD2-related TaqIA polymorphism modulates motivation to smoke. Nicotine Tob Res (2009) 0.84
Affective trajectories before and after a quit attempt among smokers with current depressive disorders. Nicotine Tob Res (2013) 0.84
On blending practice and research: the search for commonalities in substance abuse treatment. Subst Abus (2006) 0.83
Desensitization of δ-opioid receptors in nucleus accumbens during nicotine withdrawal. Psychopharmacology (Berl) (2010) 0.83
Transition from moderate to excessive drug intake: change in hedonic set point. Science (1998) 5.66
Substance use disorders in patients with posttraumatic stress disorder: a review of the literature. Am J Psychiatry (2001) 3.69
Modulation of cocaine self-administration in the rat through D-3 dopamine receptors. Science (1993) 3.67
Neural mechanisms underlying nicotine addiction: acute positive reinforcement and withdrawal. Nicotine Tob Res (2000) 3.33
Dramatic decreases in brain reward function during nicotine withdrawal. Nature (1998) 3.21
Rapid and ultrarapid opioid detoxification techniques. JAMA (1998) 3.16
Excessive ethanol drinking following a history of dependence: animal model of allostasis. Neuropsychopharmacology (2000) 3.15
Corticotropin releasing factor receptor 1-deficient mice display decreased anxiety, impaired stress response, and aberrant neuroendocrine development. Neuron (1998) 3.08
Suppression of psychoactive effects of cocaine by active immunization. Nature (1995) 3.05
Mice deficient for corticotropin-releasing hormone receptor-2 display anxiety-like behaviour and are hypersensitive to stress. Nat Genet (2000) 3.04
Drug dependence: stress and dysregulation of brain reward pathways. Drug Alcohol Depend (1998) 2.94
A randomized controlled trial of auricular acupuncture for cocaine dependence. Arch Intern Med (2000) 2.87
Oral alcohol self-administration stimulates dopamine release in the rat nucleus accumbens: genetic and motivational determinants. J Pharmacol Exp Ther (1993) 2.79
Increase of extracellular corticotropin-releasing factor-like immunoreactivity levels in the amygdala of awake rats during restraint stress and ethanol withdrawal as measured by microdialysis. J Neurosci (1995) 2.70
Effects of moderate alcohol consumption on the central nervous system. Alcohol Clin Exp Res (1998) 2.60
Intra-amygdala muscimol decreases operant ethanol self-administration in dependent rats. Alcohol Clin Exp Res (1996) 2.51
Activation of corticotropin-releasing factor in the limbic system during cannabinoid withdrawal. Science (1997) 2.50
Postcocaine anhedonia. An animal model of cocaine withdrawal. Neuropsychopharmacology (1991) 2.41
A randomized trial of buprenorphine maintenance for heroin dependence in a primary care clinic for substance users versus a methadone clinic. Am J Med (1998) 2.37
Animal models of drug craving. Psychopharmacology (Berl) (1993) 2.32
Microinjection of a corticotropin-releasing factor antagonist into the central nucleus of the amygdala reverses anxiogenic-like effects of ethanol withdrawal. Brain Res (1993) 2.27
Cocaine vaccines: antibody protection against relapse in a rat model. Proc Natl Acad Sci U S A (2000) 2.16
Destruction of dopamine in the nucleus accumbens selectively attenuates cocaine but not heroin self-administration in rats. Psychopharmacology (Berl) (1984) 2.13
Dopamine D1 receptor mutant mice are deficient in striatal expression of dynorphin and in dopamine-mediated behavioral responses. Cell (1994) 2.05
Persistent increase in the motivation to take heroin in rats with a history of drug escalation. Neuropsychopharmacology (2000) 2.04
CRF antagonist reverses the "anxiogenic" response to ethanol withdrawal in the rat. Psychopharmacology (Berl) (1991) 2.04
Long-lasting increase in the set point for cocaine self-administration after escalation in rats. Psychopharmacology (Berl) (1999) 2.01
Decreased brain reward produced by ethanol withdrawal. Proc Natl Acad Sci U S A (1995) 2.00
Buprenorphine vs methadone maintenance treatment for concurrent opioid dependence and cocaine abuse. Arch Gen Psychiatry (1997) 1.99
Construct validity of a self-stimulation threshold paradigm: effects of reward and performance manipulations. Physiol Behav (1992) 1.96
Ethanol self-administration restores withdrawal-associated deficiencies in accumbal dopamine and 5-hydroxytryptamine release in dependent rats. J Neurosci (1996) 1.95
GABAA receptor antagonism in the extended amygdala decreases ethanol self-administration in rats. Eur J Pharmacol (1995) 1.93
Appetite-suppressing effects of urocortin, a CRF-related neuropeptide. Science (1996) 1.91
Three methods of opioid detoxification in a primary care setting. A randomized trial. Ann Intern Med (1997) 1.87
Corticotropin releasing factor produces behavioural activation in rats. Nature (1982) 1.82
Nicotine transdermal patch and atypical antipsychotic medications for smoking cessation in schizophrenia. Am J Psychiatry (2000) 1.82
A second-generation vaccine protects against the psychoactive effects of cocaine. Proc Natl Acad Sci U S A (2001) 1.78
Functional interaction between opioid and cannabinoid receptors in drug self-administration. J Neurosci (2001) 1.78
Heroin and cocaine intravenous self-administration in rats: mediation by separate neural systems. Psychopharmacology (Berl) (1982) 1.76
Should protracted withdrawal from drugs be included in DSM-IV? Am J Psychiatry (1993) 1.71
Concurrent validity of the addiction severity index. J Nerv Ment Dis (1983) 1.68
mu-Opioid receptor knockout mice do not self-administer alcohol. J Pharmacol Exp Ther (2000) 1.67
Performance norms for a rhesus monkey neuropsychological testing battery: acquisition and long-term performance. Brain Res Cogn Brain Res (1999) 1.66
Overproduction of corticotropin-releasing factor in transgenic mice: a genetic model of anxiogenic behavior. J Neurosci (1994) 1.65
Prognostic significance of psychopathology in treated opiate addicts. A 2.5-year follow-up study. Arch Gen Psychiatry (1986) 1.62
Corticotropin-releasing factor and neuropeptide Y: role in emotional integration. Trends Neurosci (1994) 1.61
Basal extracellular dopamine levels in the nucleus accumbens are decreased during cocaine withdrawal after unlimited-access self-administration. Brain Res (1992) 1.60
Effects of the dopamine D-1 antagonist SCH 23390 microinjected into the accumbens, amygdala or striatum on cocaine self-administration in the rat. Brain Res (1995) 1.59
Blockade of nicotine self-administration with nicotinic antagonists in rats. Pharmacol Biochem Behav (1999) 1.58
Intraventricular corticotropin-releasing factor enhances behavioral effects of novelty. Life Sci (1982) 1.57
Reward and somatic changes during precipitated nicotine withdrawal in rats: centrally and peripherally mediated effects. J Pharmacol Exp Ther (2000) 1.56
Disulfiram versus placebo for cocaine dependence in buprenorphine-maintained subjects: a preliminary trial. Biol Psychiatry (2000) 1.55
Prediction of dopamine transporter binding availability by genotype: a preliminary report. Am J Psychiatry (2000) 1.54
Gender differences in cocaine use and treatment response. J Subst Abuse Treat (1993) 1.50
Cocaine- but not food-seeking behavior is reinstated by stress after extinction. Psychopharmacology (Berl) (1997) 1.50
Disulfiram effects on acute cocaine administration. Drug Alcohol Depend (1998) 1.50
Modulation of social memory in male rats by neurohypophyseal peptides. Psychopharmacology (Berl) (1987) 1.49
Extinction and recovery of cocaine self-administration following 6-hydroxydopamine lesions of the nucleus accumbens. Pharmacol Biochem Behav (1980) 1.48
Effects of dopamine D-1 and D-2 antagonists on cocaine self-administration under different schedules of reinforcement in the rat. J Pharmacol Exp Ther (1994) 1.47
Corticotropin-releasing factor antagonist attenuates the "anxiogenic-like" effect in the defensive burying paradigm but not in the elevated plus-maze following chronic cocaine in rats. Psychopharmacology (Berl) (1999) 1.46
Operant self-administration of sweetened versus unsweetened ethanol: effects on blood alcohol levels. Alcohol Clin Exp Res (1999) 1.45
Genetic differences in response to novelty and spatial memory using a two-trial recognition task in mice. Neurobiol Learn Mem (2000) 1.44
Modulation of anxiety and neuropeptide Y-Y1 receptors by antisense oligodeoxynucleotides. Science (1993) 1.43
Anxiolytic-like action of neuropeptide Y: mediation by Y1 receptors in amygdala, and dissociation from food intake effects. Neuropsychopharmacology (1993) 1.43
Treatment of cocaine abuse with mazindol. Lancet (1989) 1.43
Disruption of cocaine self-administration following 6-hydroxydopamine lesions of the ventral tegmental area in rats. Pharmacol Biochem Behav (1982) 1.41
Rapid detoxification from opioid dependence. Am J Psychiatry (1989) 1.40
Concurrent use of cocaine and alcohol is more potent and potentially more toxic than use of either alone--a multiple-dose study. Biol Psychiatry (1998) 1.40
Corticotropin-releasing factor potentiates acoustic startle in rats: blockade by chlordiazepoxide. Psychopharmacology (Berl) (1986) 1.38
Oral ethanol self-administration in rats is reduced by the administration of dopamine and glutamate receptor antagonists into the nucleus accumbens. Psychopharmacology (Berl) (1992) 1.38
Corticotropin-releasing factor antagonist reduces emotionality in socially defeated rats via direct neurotropic action. Brain Res (1992) 1.35
Drugs of abuse and the brain. Proc Assoc Am Physicians (1999) 1.35
Time-dependent quantifiable withdrawal from ethanol in the rat: effect of method of dependence induction. Alcohol (1996) 1.35
Urinary free-cortisol levels in posttraumatic stress disorder patients. J Nerv Ment Dis (1986) 1.35
Relative sensitivity to naloxone of multiple indices of opiate withdrawal: a quantitative dose-response analysis. J Pharmacol Exp Ther (1994) 1.35
Day treatment versus enhanced standard methadone services for opioid-dependent patients: a comparison of clinical efficacy and cost. Am J Psychiatry (1999) 1.34
Nicotine dependence and schizophrenia. Hosp Community Psychiatry (1994) 1.32
Vaccines against drug abuse. Clin Pharmacol Ther (2011) 1.32
Quantitative morphology of the caudate and putamen in patients with cocaine dependence. Am J Psychiatry (2001) 1.30
Increased ethanol self-administration in delta-opioid receptor knockout mice. Alcohol Clin Exp Res (2001) 1.29
Role of different brain structures in the expression of the physical morphine withdrawal syndrome. J Pharmacol Exp Ther (1992) 1.29
Metabotropic glutamate 5 receptor antagonist MPEP decreased nicotine and cocaine self-administration but not nicotine and cocaine-induced facilitation of brain reward function in rats. Ann N Y Acad Sci (2003) 1.28
Nucleus accumbens and amygdala are possible substrates for the aversive stimulus effects of opiate withdrawal. Neuroscience (1990) 1.28
Increased ethanol self-administration after a period of imposed ethanol deprivation in rats trained in a limited access paradigm. Alcohol Clin Exp Res (1997) 1.26
Psychiatric disorders in relatives of probands with opiate addiction. Arch Gen Psychiatry (1991) 1.26
Prolonged tolerance, dependence and abstinence following subcutaneous morphine pellet implantation in the rat. Eur J Pharmacol (1994) 1.26
Noradrenergic dysregulation during discontinuation of cocaine use in addicts. Arch Gen Psychiatry (1994) 1.22
Ethnic and gender differences among opiate addicts. Int J Addict (1985) 1.22
Office-based treatment for opioid dependence: reaching new patient populations. Am J Psychiatry (2001) 1.21
Pathological gambling. JAMA (2001) 1.21
Elevated striatal dopamine transporters during acute cocaine abstinence as measured by [123I] beta-CIT SPECT. Am J Psychiatry (1998) 1.19
Desipramine facilitation of initial cocaine abstinence. Arch Gen Psychiatry (1989) 1.19
Central dopamine hyperactivity in rats mimics abnormal acoustic startle response in schizophrenics. Biol Psychiatry (1986) 1.17
Prognostic factors in Buprenorphine- versus methadone-maintained patients. J Nerv Ment Dis (1998) 1.17
A multicenter trial of bupropion for cocaine dependence in methadone-maintained patients. Drug Alcohol Depend (1995) 1.17
Contingency management interventions: from research to practice. Am J Psychiatry (2001) 1.17
Dependence-induced alcohol drinking by alcohol-preferring (P) rats and outbred Wistar rats. Alcohol Clin Exp Res (2008) 1.16
A 2.5-year follow-up of cocaine use among treated opioid addicts. Have our treatments helped? Arch Gen Psychiatry (1987) 1.16
The role of corticotropin-releasing factor in the anxiogenic effects of ethanol withdrawal. Ann N Y Acad Sci (1994) 1.16
Concurrent cocaine-ethanol ingestion in humans: pharmacology, physiology, behavior, and the role of cocaethylene. Psychopharmacology (Berl) (1993) 1.15